92 related articles for article (PubMed ID: 2188335)
21. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.
Colás C; Monzón S; Venturini M; Lezaun A
J Allergy Clin Immunol; 2006 Apr; 117(4):810-6. PubMed ID: 16630938
[TBL] [Abstract][Full Text] [Related]
22. Safety, tolerability and efficacy of sublingual allergoid immunotherapy with a 4-day shortened build-up phase.
Giordano T; Quarta C; Bruno ME; Falagiani P; Riva G
Eur Ann Allergy Clin Immunol; 2006 Nov; 38(9):310-2. PubMed ID: 17191751
[TBL] [Abstract][Full Text] [Related]
23. The clinical and immunologic efficacy of immunotherapy with modified ragweed extract (allergoid) for ragweed hay fever.
Meriney DK; Kothari H; Chinoy P; Grieco MH
Ann Allergy; 1986 Jan; 56(1):34-8. PubMed ID: 2418713
[TBL] [Abstract][Full Text] [Related]
24. Clinical evaluation of hyposensitization in allergic rhinitis: comparison of the results obtained with three different extracts. Material from a 3-year study.
Verstraeten JM; Verstraeten AF
Ann Allergy; 1987 Jun; 58(6):416-20. PubMed ID: 3592311
[TBL] [Abstract][Full Text] [Related]
25. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
26. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
27. [Results of specific hyposensitization in children with pollinosis].
Schuster R; Quassem A; Sollich V; Thal W
Kinderarztl Prax; 1991; 59(7-8):206-10. PubMed ID: 1921171
[TBL] [Abstract][Full Text] [Related]
28. The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children.
Rolinck-Werninghaus C; Hamelmann E; Keil T; Kulig M; Koetz K; Gerstner B; Kuehr J; Zielen S; Schauer U; Kamin W; Von Berg A; Hammermann J; Weinkauf B; Weidinger G; Stenglein S; Wahn U;
Allergy; 2004 Sep; 59(9):973-9. PubMed ID: 15291906
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
[TBL] [Abstract][Full Text] [Related]
30. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract.
Amar SM; Harbeck RJ; Sills M; Silveira LJ; O'Brien H; Nelson HS
J Allergy Clin Immunol; 2009 Jul; 124(1):150-156.e1-5. PubMed ID: 19523672
[TBL] [Abstract][Full Text] [Related]
31. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
[TBL] [Abstract][Full Text] [Related]
32. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
Silny W; Czarnecka-Operacz M
Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
[TBL] [Abstract][Full Text] [Related]
33. Pollinex Parietaria (Bencard Parietaria), a new allergoid for treatment of patients sensitive to Parietaria pollen.
Resta O; Carnimeo N; Foschino MP; Taylor I; Wheeler AW; Youlten LJ
J Investig Allergol Clin Immunol; 1991 Apr; 1(2):129-37. PubMed ID: 1669569
[TBL] [Abstract][Full Text] [Related]
34. [Pre-seasonal treatment of hayfever with a pollen depot extract (author's transl)].
Düngemann H; von Mayenburg J; Rakoski J
Med Klin; 1977 Jun; 72(24):1071-9. PubMed ID: 882040
[TBL] [Abstract][Full Text] [Related]
35. Accelerated Dose Escalation with Three Injections of an Aluminum Hydroxide-Adsorbed Allergoid Preparation of Six Grasses Is Safe for Patients with Moderate to Severe Allergic Rhinitis.
Kopp MV; Bovermann X; Klimek L
Int Arch Allergy Immunol; 2020; 181(2):94-102. PubMed ID: 31865326
[TBL] [Abstract][Full Text] [Related]
36. Accelerated Dose Escalation with 3 Injections of an Aluminum Hydroxide-Adsorbed Allergoid Preparation of 6 Grasses Is Safe for Children and Adolescents with Moderate to Severe Allergic Rhinitis.
Bovermann X; Ricklefs I; Vogelberg C; Klimek L; Kopp MV
Int Arch Allergy Immunol; 2021; 182(6):524-534. PubMed ID: 33503610
[TBL] [Abstract][Full Text] [Related]
37. [The influence of a three-year preseasonal specific immunotherapy on selected parameters of allergic inflammation in pollinosis patients].
Fal AM; Gietkiewicz K; Obojski A; Medrala W; Małolepszy J
Pneumonol Alergol Pol; 2002; 70(1-2):78-86. PubMed ID: 12148181
[TBL] [Abstract][Full Text] [Related]
38. [Specific desensitization of pollinosis by various allergen extracts (author's transl)].
Schuchardt P; Hühnerfuss S
Z Erkr Atmungsorgane; 1976 Aug; 146(2):115-9. PubMed ID: 828359
[TBL] [Abstract][Full Text] [Related]
39. [A clinical evaluation of methods fpr specific hyposensitization in pollinosis].
Bulakhova EK
Vrach Delo; 1991 Mar; (3):63-5. PubMed ID: 2042353
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy of oral and parenteral hyposensitization with pollen extracts].
Urbanek R; Kuhn W; Binder U
Dtsch Med Wochenschr; 1983 Sep; 108(38):1433-7. PubMed ID: 6884233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
